Purchase Order 75N98026P01313

This is a firm fixed-price purchase order for the renewal of VarSeq software licenses, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to the prime contractor Golden Helix Inc. The award is valued at $4,745.00 and does not have a set-aside designation. Golden Helix is a global bioinformatics company that provides genomic data analysis software and services to support biomedical...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed-price purchase order to Golden Helix Inc. for $11,745.00 on December 18, 2020. The order procures a software license for SNP & Variation Suite (SVS), a genomic data analysis platform that enables the government laboratory to open, access, manipulate, and analyze large-scale genetic datasets generated from sequencing and genotyping operations. Place of performance is Bozeman, Montana. The purchase...

The National Institute on Drug Abuse awarded a purchase order to Seven Bridges Genomics Inc. for $749,650.33 on May 1, 2023, for integration of a Single Sign On solution within Cavatica and six months of a Tier 1 Cavatica license, with options for subsequent Cavatica licenses in 2024 and 2025. No set-aside applied. Performance occurs in Charlestown, Massachusetts. The contract carries a firm fixed price and completion date of October 31, 2025. In FY2024, the prime invoiced $137 thousand across...

This is a $15,000 Firm Fixed Price purchase order awarded by the National Eye Institute (NEI), a part of the National Institutes of Health (NIH), to Golden Helix Inc., a global bioinformatics company. The contract is for the provision of Golden Helix's genomic data analysis software, including SNP & Variation Suite, VSClinical, and VarSeq, which enable federal researchers to process, analyze, and interpret large volumes of genomic data generated through next-generation sequencing efforts....

This is a firm-fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Golden Helix Inc., a for-profit software company specializing in genetic data analysis tools. The $15,000.00 contract is for the renewal of licensed software used to analyze sequencing data, supporting an ongoing NHGRI project studying genetic variation. The software will be used by IVONA AKSENTIJEVIC and other lab...

The National Human Genome Research Institute awarded a purchase order to Enterprise Technology Solutions, Inc., a Women-Owned Small Business, for $169,450 on June 1, 2026, to supply one-year FreezerPro support license and on-premises Limfinity license renewals. Performance takes place in Berwyn Heights, Maryland. The order covers renewal of software licenses and technical support services for laboratory information management and patient data systems supporting the Undiagnosed Diseases...

The National Human Genome Research Institute awarded a purchase order to Virti Inc. for $24,999.00 on April 23, 2026 to supply 100 licenses for renewal of the Virti Platform, a virtual reality simulation software used in the SHARE VR study. Work is performed at Virti Inc. facilities in New York, New York and at NHGRI in Bethesda, Maryland. The order includes weekday technical support and access to programmed virtual simulation environments with interactive avatars, secure web-based...

This is a $43,200.00 firm fixed-price purchase order contract awarded by the National Eye Institute (NEI) to Golden Helix Inc. for an SNP & Variation Suite (SVS) server license to support up to 11 SVS users. The contract has an ultimate completion date of December 21, 2027. Golden Helix is a global bioinformatics company that provides genetic data analysis software and services to federal agencies like the NIH, CDC, and NHGRI. This contract represents one of several fixed-price purchase...

<p>The Department of Health and Human Services, Northeast Area issued a $30,063.52 delivery order to Illumina, Inc. on June 23, 2025, for MiSeq i100 Plus supplies and consumables.</p> <p>Place of performance is Calverton, MD. The order is firm fixed price with an ultimate completion date of June 22, 2030. No set-aside was used.</p>

This is a federal contract award by the Office of Research and Development, a civilian agency, to Illumina, Inc., a for-profit manufacturer of goods, for the provision of annual licenses and maintenance for the Partek Genomics Suite and Pathway software. The contract has a ceiling value of $221,650.00 and a period of performance running from October 1, 2023 through September 30, 2026, with a base year plus two option years. The contract is a firm fixed-price purchase order and does not utilize...